OWA
IDXX icon

Outlook Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Outlook Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$333K Sell
632
-6
-0.9% -$3.37K 0.07% 237
2026
Q1 		$358K Sell
638
-3
-0.5% -$1.92K 0.09% 215
2025
Q4 		$434K Sell
641
-15
-2% -$10.2K 0.1% 180
2025
Q3 		$419K Sell
656
-193
-23% -$117K 0.1% 173
2025
Q2 		$455K Sell
849
-17
-2% -$8.13K 0.12% 162
2025
Q1 		$364K Buy
866
+14
+2% +$6.08K 0.1% 194
2024
Q4 		$352K Buy
852
+145
+21% +$63.6K 0.1% 205
2024
Q3 		$357K Buy
707
+64
+10% +$31.1K 0.1% 192
2024
Q2 		$313K Buy
643
+102
+19% +$51.2K 0.1% 209
2024
Q1 		$292K Buy
541
+111
+26% +$60.7K 0.09% 214
2023
Q4 		$239K Buy
+430
New +$202K 0.08% 199

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Outlook Wealth Advisors's IDXX Position: Q2 2026 in Review

Outlook Wealth Advisors reduced its Idexx Laboratories (IDXX) stake by 0.94% in Q2 2026, selling an estimated $3.37K and leaving 632 shares worth $333K. The position accounts for 0.07% of the portfolio, ranked #237.

Outlook Wealth Advisors first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $455K in Q2 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Outlook Wealth Advisors held 632 shares of Idexx Laboratories worth $333K as of Q2 2026.
  • Outlook Wealth Advisors sold 6 Idexx Laboratories shares in Q2 2026, an estimated $3.37K.
  • Idexx Laboratories made up 0.07% of Outlook Wealth Advisors's portfolio in Q2 2026, its #237 holding.
  • Outlook Wealth Advisors first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • Outlook Wealth Advisors's Idexx Laboratories position peaked at $455K in Q2 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Outlook Wealth Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.